Ibrutinib plus bendamustine and rituximab in untreated mantle-cell lymphoma
Keywords:
-Downloads
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.